WKY |
afferent arteriolar plasma protein concentration |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood total protein amount |
male |
0 days
| 6 |
4.7 |
g/dl |
0.2 |
0.49 |
plasma total protein analysis |
renal afferent arteriole |
0.0 |
PA IV 50mg/kg |
23 |
days |
|
rt |
100568 |
2479 |
MWF/ZtmRrrc |
afferent arteriolar plasma protein concentration |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
blood total protein amount |
male |
246 days
| 8 |
5.6 |
g/dl |
0.18 |
0.5 |
o-Phthalaldehyde fluorescent protein assay |
|
0.0 |
|
0 |
|
o-Phthalaldehyde fluorescent protein assay (MMO:0000730) |
|
100949 |
2541 |
MWF |
afferent arteriolar plasma protein concentration |
castor oil (for 7 days) |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
blood total protein amount |
male |
133 days-147 days |
7 |
5.4 |
g/dl |
0.19 |
0.5 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
110100 |
3163 |
MW |
afferent arteriolar plasma protein concentration |
nephrectomy (for 28 days) then enalapril (50 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood total protein amount |
male |
0 days
| 8 |
5.5 |
g/dl |
0.1 |
0.28 |
micropuncture fluid collection |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
101020 |
2561 |
MWF/Ztm |
afferent arteriolar plasma protein concentration |
arterial catheter implantation and controlled hemorrhage |
Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. |
blood total protein amount |
male |
112 days-147 days |
8 |
5.1 |
g/dl |
0.18 |
0.5 |
micropuncture fluid collection |
|
0.0 |
|
0 |
|
|
14 to 16 um OD |
109211 |
3138 |
MWF |
afferent arteriolar plasma protein concentration |
cyclosporine A (50 mg/kg/d) (for 7 days) and lacidipine (1 mg/kg/d) (for 7 days) |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
blood total protein amount |
male |
133 days-147 days |
7 |
5.5 |
g/dl |
0.15 |
0.4 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
110102 |
3163 |
MWF/ZtmRrrc |
afferent arteriolar plasma protein concentration |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
blood total protein amount |
male |
126 days
| 7 |
5.5 |
g/dl |
0.08 |
0.2 |
o-Phthalaldehyde fluorescent protein assay |
|
0.0 |
|
0 |
|
o-Phthalaldehyde fluorescent protein assay (MMO:0000730) |
|
100947 |
2541 |
WKY |
afferent arteriolar plasma protein concentration |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood total protein amount |
male |
0 days
| 9 |
5.4 |
g/dl |
0.1 |
0.3 |
plasma total protein analysis |
renal afferent arteriole |
0.0 |
|
0 |
|
|
ca |
100567 |
2479 |
WKY |
afferent arteriolar plasma protein concentration |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood total protein amount |
male |
0 days
| 8 |
5.5 |
g/dl |
0.1 |
0.28 |
plasma total protein analysis |
renal afferent arteriole |
0.0 |
PA IV 50mg/kg |
0 |
|
|
ca |
100571 |
2479 |
MW |
afferent arteriolar plasma protein concentration |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood total protein amount |
male |
0 days
| 8 |
5.5 |
g/dl |
0.1 |
0.28 |
micropuncture fluid collection |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
101019 |
2561 |
WKY |
afferent arteriolar plasma protein concentration |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood total protein amount |
male |
0 days
| 8 |
5.6 |
g/dl |
0.1 |
0.28 |
plasma total protein analysis |
renal afferent arteriole |
0.0 |
|
0 |
|
|
ca |
100569 |
2479 |
MWF/ZtmRrrc |
afferent arteriolar plasma protein concentration |
enalapril (50 mg/l) (for 60 days) |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
blood total protein amount |
male |
126 days
| 10 |
5.2 |
g/dl |
0.09 |
0.3 |
o-Phthalaldehyde fluorescent protein assay |
renal afferent arteriole |
0.0 |
|
0 |
|
o-Phthalaldehyde fluorescent protein assay (MMO:0000730) |
|
100962 |
2541 |
MWF/ZtmRrrc |
afferent arteriolar plasma protein concentration |
enalapril (50 mg/l) (for 182 days) |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
blood total protein amount |
male |
246 days
| 6 |
5.6 |
g/dl |
0.16 |
0.4 |
o-Phthalaldehyde fluorescent protein assay |
|
0.0 |
|
0 |
|
o-Phthalaldehyde fluorescent protein assay (MMO:0000730) |
|
100950 |
2541 |
WKY |
afferent arteriolar plasma protein concentration |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood total protein amount |
male |
0 days
| 9 |
5.6 |
g/dl |
0.1 |
0.3 |
plasma total protein analysis |
renal afferent arteriole |
0.0 |
PA IV 50mg/kg |
0 |
|
|
ca |
100570 |
2479 |
MWF/ZtmRrrc |
afferent arteriolar plasma protein concentration |
enalapril (50 mg/l) (for 60 days) |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
blood total protein amount |
male |
126 days
| 8 |
5.6 |
g/dl |
0.01 |
0.03 |
o-Phthalaldehyde fluorescent protein assay |
|
0.0 |
|
0 |
|
o-Phthalaldehyde fluorescent protein assay (MMO:0000730) |
|
100948 |
2541 |
MWF/ZtmRrrc |
afferent arteriolar plasma protein concentration |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
blood total protein amount |
male |
126 days
| 8 |
5.3 |
g/dl |
0.28 |
0.8 |
o-Phthalaldehyde fluorescent protein assay |
renal afferent arteriole |
0.0 |
|
0 |
|
o-Phthalaldehyde fluorescent protein assay (MMO:0000730) |
|
100961 |
2541 |
MW |
afferent arteriolar plasma protein concentration |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood total protein amount |
male |
0 days
| 8 |
5.7 |
g/dl |
0.1 |
0.28 |
micropuncture fluid collection |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
101021 |
2561 |
MWF/Ztm |
afferent arteriolar plasma protein concentration |
arterial catheter implantation and controlled hemorrhage |
Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. |
blood total protein amount |
female |
126 days-147 days |
8 |
5.2 |
g/dl |
0.11 |
0.3 |
micropuncture fluid collection |
|
0.0 |
|
0 |
|
|
14 to 16 um OD |
109212 |
3138 |
MWF |
afferent arteriolar plasma protein concentration |
cyclosporine A (50 mg/kg/d) (for 7 days) |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
blood total protein amount |
male |
133 days-147 days |
6 |
5.4 |
g/dl |
0.12 |
0.3 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
110101 |
3163 |